Maintenance with low-dose cytarabine for acute myeloid leukemia in complete remission-Reference-Cited by-同舟云学术

Maintenance with low-dose cytarabine for acute myeloid leukemia in complete remission

Published:1992-08 Issue:2 Volume:65 Page:71-74
ISSN:0939-5555
Container-title:Annals of Hematology
language:en
Short-container-title:Ann Hematol

Author:

Archimbaud E.,Anglaret B.,Thomas X.,Jaubert J.,Sebban C.,Guyotat D.,Fiere D.

Publisher

Springer Science and Business Media LLC

Subject

Hematology,General Medicine

Link

http://link.springer.com/content/pdf/10.1007/BF01698132.pdf

Reference17 articles.

1. Alessandrino EP, Orlandi E, Brusamolino E, Lazzarino M, Bernasconi C (1985) Low-dose ara-C in acute leukemia after a myelodysplastic syndrome and in elderly leukemia. Am J Hematol 20: 191–193

2. Bennett JM, Catovsky D, Daniel MT, Flandrin G, Galton DAG, Gralnick HR, Sultan C (1985) Proposed revised criteria for the classification of acute myeloid leukemia: a report of the French-American-British Cooperative Group. Ann Intern Med 103: 626–629

3. Bolwell BJ, Cassileth PA, Gale RP (1987) Low-dose cytosine arabinoside in myelodysplasia and acute myelogenous leukemia: a review. Leukemia 1: 575–579

4. Cheson BD, Jasperse DM, Simon R, Friedman MA (1986) A critical appraisal of low-dose cytosine arabinoside in patients with acute non-lymphocytic leukemia and myelodysplastic syndromes. J Clin Oncol 4: 1857–1864

5. Ellison RR, Holland JF, Weil M, Jacquillat C, Boiron M, Bernard J, Sawitsky A, Rosner F, Gussoff B, Silver RT, Karanas A, Cuttner J, Spurr CL, Hayes DM, Bloom J, Leone LA, Haurani F, Kyle R, Hutchinson JL, Forcier RJ, Moon JH (1968) Arabinosyl cytosine: a useful agent in the treatment of acute leukemia in adults. Blood 32: 507–523

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Tipifarnib as maintenance therapy did not improve disease-free survival in patients with acute myelogenous leukemia at high risk of relapse: Results of the phase III randomized E2902 trial;Leukemia Research;2021-12

2. Targeted and cytotoxic therapies as maintenance treatment for non-transplant eligible patients with acute myeloid leukemia;Blood Reviews;2021-11

3. Acute myeloid leukemia in the elderly (age 70 yr or older): long-term survivors;European Journal of Haematology;2016-10-12

4. Low-dose cytarabine maintenance therapy vs observation after remission induction in advanced acute myeloid leukemia: an Eastern Cooperative Oncology Group Trial (E5483);Leukemia;2000-08

5. Disappearance of AML1-MTG8 transcript by reverse transcriptase polymerase chain reaction in a patient in remission of acute myeloid leukemia (M2) after low-dose cytosine arabinoside;Leukemia Research;1998-09